Therapeutic Advances in Pulmonary and Critical Care Medicine is a leading journal published by SAGE Publications Ltd, dedicated to advancing the fields of pulmonary and critical care medicine. With an emphasis on innovative research, clinical practice, and therapeutic strategies, this journal aims to provide an essential platform for professionals, researchers, and students alike to share groundbreaking findings and insights in a rapidly evolving medical landscape. As an Open Access publication, it ensures that high-quality research is easily accessible to a global audience, facilitating knowledge sharing and collaboration. Though specific metrics such as H-Index and Scopus rankings are currently unlisted, the journal's commitment to rigorous peer review and high academic standards positions it as a vital resource for anyone involved in pulmonary and critical care medicine. With its dedicated editorial board and a diverse array of topics covered, Therapeutic Advances in Pulmonary and Critical Care Medicine stands at the forefront of fostering the latest advancements in the field.

REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.

Welcome to the Journal of Clinical and Diagnostic Research, a leading open-access journal published by the PREMCHAND SHANTIDEVI RESEARCH FOUNDATION since 2007. This journal serves as a crucial platform for researchers and professionals in the fields of biochemistry, genetics, and molecular biology, with a particular focus on clinical biochemistry. The journal is recognized for its commitment to disseminating high-quality research, fostering academic dialogue, and enabling practitioners to stay at the forefront of advancements in diagnostic methods. With an ISSN of 2249-782X, the journal enhances accessibility to critical research findings and discussions, ensuring that the scientific community and interested students can engage with valuable insights. Although coverage has been discontinued in Scopus since 2018, its rankings within the clinical biochemistry domain reflect a dedicated scholarly impact that continues to influence research trajectories. We invite you to explore the wealth of knowledge presented in the Journal of Clinical and Diagnostic Research and contribute to the evolving discourse in clinical science.

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Annals of Medicine and Surgery is a reputable multidisciplinary journal published by Lippincott Williams & Wilkins, focusing on a broad range of topics pertinent to both medicine and surgery. With an ISSN of 2049-0801, this journal aims to disseminate innovative research findings and clinical studies that contribute to the advancement of medical and surgical practices. Since its inception in 2012, it has established itself within the academic community, achieving a Q3 ranking in both the Medicine (miscellaneous) and Surgery categories for 2022. Despite its coverage being discontinued in Scopus, the journal continues to receive attention, ranked in the 45th percentile for its fields, illustrating its growing influence. Researchers, healthcare professionals, and students will find in this journal an invaluable resource for enhancing their understanding and staying updated with evolving medical and surgical landscapes. Access options are currently managed through institutional subscriptions, ensuring the dissemination of high-quality research to a diverse audience.

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Acta Medica Portuguesa is a distinguished journal in the field of General Medicine, published by ORDEM MEDICOS. Since its inception, this open-access journal has been a vital platform for disseminating impactful research and reviews in various aspects of medicine, particularly from Portuguese and international perspectives. With an ISSN of 0870-399X and an E-ISSN of 1646-0758, it caters to a global audience and has been open-access since 2003, ensuring maximum reach and visibility of its contributions. Despite its recent Q4 ranking in the Medicine (miscellaneous) category for 2023, it holds a commendable rank of 248 out of 636 in Scopus, indicating a strong percentile standing of 61%. This journal not only chronicles pivotal findings and advances in the medical field but also fosters collaboration and dialogue among researchers, professionals, and students alike. Based in Portugal at AV ALMIRANTE GAGO COUTINHO, 151, LISBON 1749-084, PORTUGAL, Acta Medica Portuguesa continues to contribute significantly to the medical literature landscape, inviting submissions that offer novel insights and enhance medical knowledge.